Pathologic features of prognostic significance for adrenocortical carcinoma after curative resection

Archives of Surgery

Volumn 134, Issue 2, 1999, Pages 181-185

  Harrison, Lawrence E ^a   Gaudin, Paul B ^b   Brennan, Murray F ^b  

^a University of Medicine and Dentistry of New Jersey   (United States)

^b MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADRENAL CORTEX CARCINOMA; ADULT; AGED; ARTICLE; BLEEDING; CANCER STAGING; CANCER SURGERY; CLINICAL ARTICLE; FEMALE; HIGH RISK POPULATION; HISTOPATHOLOGY; HUMAN; MALE; MITOSIS RATE; PRIORITY JOURNAL; PROGNOSIS; RISK FACTOR; SURVIVAL RATE; TUMOR BIOPSY; TUMOR VOLUME;

ADRENAL GLAND NEOPLASMS; ADRENOCORTICAL CARCINOMA; ADULT; AGED; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; PROGNOSIS; RETROSPECTIVE STUDIES; SURVIVAL RATE;

EID: 0033028078     PISSN: 00040010     EISSN: None     Source Type: Journal    
DOI: 10.1001/archsurg.134.2.181     Document Type: Article

References (16)

1. Pommier R, Brennan M. Management of adrenal neoplasms. Curr Probl Surg. 1991;28:659-739.
2. Pommier R, Brennan M. An eleven-year experience with adrenocortical carcinoma. Surgery. 1992;112:963-971.
3. Icard P, Chapuis Y, Andreassian B, Bernard A, Proye C. Adrenocortical carcinoma in surgically treated patients: a retrospective study on 156 cases by the French Association of Endocrine Surgery. Surgery. 1992;112:972-980.
4. Crucitti F, Bellatone R, Ferrante A, Boscherini M, Crucitti P, for the Italian Registry Group. The Italian registry for adrenal cortical carcinoma: analysis of a multiinstitutional series of 129 patients. Surgery. 1996;119:161-170.
5. Lee J, Berger D, el-Naggar A, et al. Surgical management, DNA content and patient survival in adrenal cortical carcinoma. Surgery. 1995;118:1090-1098.
6. Weiss L, Medeiros L, Vickery A. Pathologic features of prognostic significance in adrenocortical carcinoma. Am J Surg Pathol. 1989;13:202-206.
7. Van Slooten H, Schaberg A, Smeenk D, Moolenaar A. Morphologic characteristics of benign and malignant adrenocortical tumors. Cancer. 1985;55:766-773.
8. Luton JP, Cerdas S, Billaud L, et al. Clinical features of adrenocortical carcinoma, prognostic factors, and the effects of mitotane therapy. N Engl J Med. 1990;322:1195-1201.
9. Weiss L. Comparative histologic study of 43 metastasizing and nonmetastasizing adrenocortical tumors. Am J Surg Pathol. 1984;8:163-169.
10. Hough A, Hollifield J, Page D, Hartmann W. Prognostic factors in adrenal cortical tumors: a mathematical analysis of clinical and morphologic data. Am J Clin Pathol. 1979;72:390-399.
11. Evans H, Vassilopoulou-Selin R. Adrenal cortical neoplasms: a study of 56 cases. Am J Clin Pathol. 1996;105:76-86.
12. Cibas E, Medeiros L, Weinberg D, Gelb A, Weiss L. Cellular DNA profiles of benign and malignant adrenocortical tumors. Am J Surg Pathol. 1990;14:948-955.
13. Flyn S, Murren J, Kirby W, Honig J, Kan L, Kinder BK. P-glycoprotein expression and multidrug resistance in adrenocortical carcinoma. Surgery. 1992;112: 981-986.
14. Reincke M, Karl M, Travis W, et al. p53 Mutation in human adrenocortical neoplasms: immunohistochemical and molecular studies. J Clin Endocrinol Metab. 1994;78:790-794.
15. Sasano H, Suzuki T, Shizawa S, Kato K, Nagura H. Transforming growth factor alpha, epidermal growth factor, and epidermal growth factor receptor expression in normal and diseased human adrenal cortex by immunohistochemistry and in situ hybridization. Mod Pathol. 1994;7:741-746.
16. Schroder S, Padberg B, Achilles E, Holl K, Dralle H, Kloppel G. Immunocytochemistry in adrenocortical tumours: a clinicomorphological study of 72 neoplasms. Virchows Arch A Pathol Anat Histopathol. 1992;420:65-70.